Raymond James Financial Services Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-551	Closed	-$21K	–	3195
2020 Q4	$21K	Sell	551 -8,581	-94%	-$321K	﹤0.01%	2946
2020 Q3	$493K	Buy	9,132 +79	+0.9%	+$14.3K	﹤0.01%	1973
2020 Q2	$2.28M	Sell	9,053 -2,163	-19%	-$437K	0.01%	1057
2020 Q1	$1.76M	Buy	11,216 +1,071	+11%	+$181K	0.01%	947
2019 Q4	$1.66M	Sell	10,145 -149	-1%	-$22K	0.01%	1256
2019 Q3	$1.5M	Buy	10,294 +170	+2%	+$29.6K	0.01%	1249
2019 Q2	$2.1M	Sell	10,124 -32	-0.3%	-$6.85K	0.01%	1082
2019 Q1	$2.12M	Sell	10,156 -1,629	-14%	-$359K	0.01%	1033
2018 Q4	$2.06M	Sell	11,785 -1,663	-12%	-$332K	0.01%	883
2018 Q3	$3.05M	Sell	13,448 -820	-6%	-$133K	0.01%	855
2018 Q2	$2.16M	Buy	14,268 +119	+0.8%	+$21.6K	0.01%	975
2018 Q1	$2.59M	Sell	14,149 -352	-2%	-$79.1K	0.01%	821
2017 Q4	$3.09M	Sell	14,501 -316	-2%	-$67.6K	0.02%	726
2017 Q3	$3.18M	Buy	14,817 +608	+4%	+$119K	0.02%	714
2017 Q2	$2.69M	Buy	14,209 +746	+6%	+$146K	0.02%	751
2017 Q1	$3.33M	Buy	13,463 +704	+6%	+$173K	0.03%	616
2016 Q4	$3.23M	Buy	12,759 +767	+6%	+$176K	0.03%	583
2016 Q3	$2.44M	Buy	11,992 +3,167	+36%	+$394K	0.02%	676
2016 Q2	$792K	Sell	8,825 -336	-4%	-$26.3K	0.01%	1162
2016 Q1	$497K	Buy	9,161 +4,472	+95%	+$197K	0.01%	1256
2015 Q4	$232K	Buy	+4,689	New	+$239K	﹤0.01%	1495